A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
BioSpace | The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
While we’ve made some progress, unfortunately, it appears we still have work to do.
PINC AI™ is narrowing the gaps in maternal and infant care through standardized and timely data.
The Centers for Medicare & Medicaid Services (CMS) recently released the CY 2023 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment...
The Leapfrog Patient Safety Grade are a high priority for any healthcare organization to ensure that the true value of care is illustrated.
The Centers for Medicare & Medicaid Services (CMS) recently released its calendar year (CY) 2023 proposed rules for the Physician Fee Schedule (PFS) and...
One database offers visibility into the maternal and infant relationship to support clinical research and medical solution development that can impact perinatal health.
The Center for Medicare & Medicaid Innovation (CMMI) recently announced a new voluntary CMMI model focused on cancer care, the Enhancing Oncology Model (EOM)...
Premier responds to CMS' proposed policies on the CY 2023 payment update, 340B, N95s and CDS.
Innovation in data analytics and real-world evidence is helping life sciences companies expedite treatment development and uncover new uses for existing treatments.
Remitra™ partnered with HFMA to dig into how AP automation can help healthcare finance leaders reduce costs and optimize spend.
MedTech Intelligence | Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology.